CeriBell, Financials

CBLL Stock   20.47  0.56  2.66%   
Based on the key measurements obtained from CeriBell,'s financial statements, CeriBell, is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. Key indicators impacting CeriBell,'s financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio17.5616.7274
Sufficiently Up
Slightly volatile
Investors should never underestimate CeriBell,'s ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor CeriBell,'s cash flow, debt, and profitability to make informed and accurate decisions about investing in CeriBell,.

Net Income

(42.48 Million)

  
Understanding current and past CeriBell, Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CeriBell,'s financial statements are interrelated, with each one affecting the others. For example, an increase in CeriBell,'s assets may result in an increase in income on the income statement.

CeriBell, Stock Summary

CeriBell, competes with Primo Brands, Coca Cola, MGP Ingredients, Diageo PLC, and United Guardian. CeriBell, is entity of United States. It is traded as Stock on NASDAQ exchange.
Specialization
Healthcare, Medical Devices
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CUSIP15678C102
LocationCalifornia; U.S.A
Business Address360 North Pastoria
SectorHealthcare
IndustryMedical Devices
BenchmarkDow Jones Industrial
Websitewww.ceribell.com
Phone(800) 436 0826

CeriBell, Key Financial Ratios

CeriBell, Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CeriBell,'s current stock value. Our valuation model uses many indicators to compare CeriBell, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CeriBell, competition to find correlations between indicators driving CeriBell,'s intrinsic value. More Info.
CeriBell, is number one stock in profit margin category among its peers. It also is number one stock in operating margin category among its peers . At this time, CeriBell,'s Net Loss is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value CeriBell, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

CeriBell, Systematic Risk

CeriBell,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CeriBell, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on CeriBell, correlated with the market. If Beta is less than 0 CeriBell, generally moves in the opposite direction as compared to the market. If CeriBell, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CeriBell, is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CeriBell, is generally in the same direction as the market. If Beta > 1 CeriBell, moves generally in the same direction as, but more than the movement of the benchmark.

CeriBell, March 18, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of CeriBell, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CeriBell,. We use our internally-developed statistical techniques to arrive at the intrinsic value of CeriBell, based on widely used predictive technical indicators. In general, we focus on analyzing CeriBell, Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CeriBell,'s daily price indicators and compare them against related drivers.
When determining whether CeriBell, is a strong investment it is important to analyze CeriBell,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CeriBell,'s future performance. For an informed investment choice regarding CeriBell, Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CeriBell,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy CeriBell, Stock please use our How to buy in CeriBell, Stock guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell,. If investors know CeriBell, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CeriBell, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.06)
Revenue Per Share
10.896
Quarterly Revenue Growth
0.481
The market value of CeriBell, is measured differently than its book value, which is the value of CeriBell, that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell,'s value that differs from its market value or its book value, called intrinsic value, which is CeriBell,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell,'s market value can be influenced by many factors that don't directly affect CeriBell,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CeriBell,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if CeriBell, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CeriBell,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.